ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
2 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
1.7K
|
650K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
Maybloomer
|
255 |
105K |
10 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
105K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Maybloomer
|
14K |
5.3M |
13 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
14K
|
5.3M
|
13
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Maybloomer
|
10K |
4.0M |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
10K
|
4.0M
|
8
|
|
ASX - By Stock
|
PCK |
Re:
Ann: SPP & shareholder update webinar
|
|
Maybloomer
|
55 |
16K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
55
|
16K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Maybloomer
|
549 |
186K |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
186K
|
9
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Underwritten Share Purchase Plan to raise AUD $2.5 million
|
|
Maybloomer
|
40 |
12K |
3 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
40
|
12K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Maybloomer
|
59 |
17K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
59
|
17K
|
4
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Maybloomer
|
59 |
17K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
59
|
17K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Maybloomer
|
380 |
132K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
132K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Resubmission of NDA for Sofdra Completed
|
|
Maybloomer
|
108 |
29K |
6 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
108
|
29K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
13 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
1.7K
|
650K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Presentation
|
|
Maybloomer
|
62 |
21K |
21 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
62
|
21K
|
21
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Maybloomer
|
40 |
13K |
5 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
40
|
13K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Maybloomer
|
40 |
13K |
5 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
40
|
13K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Maybloomer
|
40 |
13K |
13 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
40
|
13K
|
13
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Investor Webinar Presentation
|
|
Maybloomer
|
5 |
2.0K |
5 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
5
|
2.0K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
7 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
1.7K
|
650K
|
7
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
3 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
1.7K
|
650K
|
3
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
5 |
08/10/23 |
08/10/23 |
ASX - By Stock
|
1.7K
|
650K
|
5
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
Maybloomer
|
20K |
16M |
10 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
20K
|
16M
|
10
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
20 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
1.7K
|
650K
|
20
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Presentation- FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
68 |
16K |
2 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
68
|
16K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
New Hartley Analyst report on Bot
|
|
Maybloomer
|
93 |
28K |
4 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
93
|
28K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Maybloomer
|
10K |
4.0M |
1 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
10K
|
4.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
Maybloomer
|
574 |
202K |
18 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
574
|
202K
|
18
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
295 |
80K |
14 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
80K
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
295 |
80K |
15 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
80K
|
15
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
295 |
80K |
7 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
80K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
295 |
80K |
4 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
80K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
295 |
80K |
5 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
80K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Maybloomer
|
295 |
80K |
6 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
295
|
80K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
11 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
1.7K
|
650K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
Maybloomer
|
60 |
25K |
3 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Maybloomer
|
681 |
310K |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
681
|
310K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Maybloomer
|
1.0K |
408K |
5 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
408K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Maybloomer
|
18K |
7.0M |
5 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
18K
|
7.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
Maybloomer
|
111 |
41K |
8 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
41K
|
8
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
18 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
1.7K
|
650K
|
18
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
6 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
1.7K
|
650K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
5 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
1.7K
|
650K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Maybloomer
|
576 |
207K |
21 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
576
|
207K
|
21
|
|
ASX - By Stock
|
PCK |
Re:
Media Thread
|
|
Maybloomer
|
1.7K |
650K |
16 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
1.7K
|
650K
|
16
|
|
ASX - By Stock
|
PCK |
Re:
Ann: PCK receives funding for 12 month pilot in Welsh care homes
|
|
Maybloomer
|
27 |
8.4K |
6 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
27
|
8.4K
|
6
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Offer Booklet
|
|
Maybloomer
|
45 |
14K |
10 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
45
|
14K
|
10
|
|
ASX - By Stock
|
PCK |
Re:
Ann: Offer Booklet
|
|
Maybloomer
|
45 |
14K |
3 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
45
|
14K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Maybloomer
|
190 |
63K |
11 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
190
|
63K
|
11
|
|
ASX - By Stock
|
FRE |
Re:
Nasal Spray
|
|
Maybloomer
|
87 |
58K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
87
|
58K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Who is ready for that 55% surge?
|
|
Maybloomer
|
44 |
12K |
5 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
44
|
12K
|
5
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Pause in Trading
|
|
Maybloomer
|
152 |
64K |
6 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
152
|
64K
|
6
|
|